AkzoNobel on the capital markets
Proposed dividend of €1.55 per share (up 7 percent on 2014)
Settlement of €622 million bond which matured on March 27, 2015
A strong case for investment
We have a portfolio of businesses with leadership positions in many markets and strong global brands in both consumer and industrial markets. There is long-term growth potential from end-user segments and we have a balanced exposure across geographical regions. We have a track record of improving returns and cash flow, as well as a history of successfully commercializing innovation. We are a clear leader in sustainability and are committed to making cities more human.
Close dialog with the capital markets
We attach great value to maintaining an open dialog with the financial community in order to promote transparency. Management gave presentations at a number of industry conferences during the year, as well as holding meetings with investors and analysts. In October, a capital markets day was held to give an update on the strategy, which featured presentations from the CEO and CFO, our three Business Area Executive Committee members, the Executive Committee member responsible for Human Resources and the Head of Integrated Supply Chain.
Listings
AkzoNobel’s common shares are listed on Euronext Amsterdam. The company is included in the AEX Index, which consists of the top 25 listed companies in the Netherlands, ranked on the basis of their turnover in the stock market and free float. The AkzoNobel weight in the AEX index was 3.89 percent at year-end 2015. During 2015, 174 million AkzoNobel shares were traded on Euronext Amsterdam (2014: 171 million). AkzoNobel has a sponsored level 1 ADR program and ADRs can be traded on the international OTCQX platform in the US.
See the table below for stock codes and ticker symbols:
Euronext ticker symbol |
AKZA |
|
ISIN common share |
NL0000009132 |
|
OTC ticker symbol |
AKZOY |
|
ISIN ADR |
US0101993055 |
|
Sedol code |
5458314 |
Key share data |
||||||||
|
|
|
|
|||||
|
2013 |
2014 |
2015 |
|||||
|
||||||||
Year-end (share price in €) |
55.71 |
57.65 |
61.68 |
|||||
Year-high (share price in €) * |
56.08 |
60.77 |
74.81 |
|||||
Year-low (share price in €) * |
42.65 |
47.63 |
55.65 |
|||||
Year-average (share price in €) |
49.32 |
54.87 |
64.91 |
|||||
Average daily trade (in € millions) |
39.8 |
36.9 |
44.1 |
|||||
Average daily trade (in millions of shares) |
0.8 |
0.7 |
0.7 |
|||||
Number of shares outstanding at year-end (in millions) |
242.6 |
246.0 |
249.0 |
|||||
Market capitalization at year-end (in € billions) |
13.5 |
14.1 |
15.4 |
|||||
Net income per share (in €) |
3.00 |
2.23 |
3.95 |
|||||
Dividend per share (in €) |
1.45 |
1.45 |
1.55 |
|||||
Dividend yield (in %) |
2.9 |
2.6 |
2.4 |
|||||
Share price performance 2015
Our share price increased 7 percent in 2015, outperforming both the DJ Stoxx Chemicals and AEX indices, and 21 percent over the term from February 2013 (when the new strategy was launched) to December 2015. For more details about our share price performance, please refer to the following graphs:
Share price performance 2015
AkzoNobel share price in €
Share price performance February 2013 – December 2015
AkzoNobel share price in €
Analyst recommendations
At year-end 2015, AkzoNobel was covered by 25 equity brokers and the following analyst recommendations were applicable (see diagram):
Analyst recommendations in %
